Hjem › Overvægt › Texas › McKinney
Overvægt kliniske forsøg i McKinney, TX
4 studier for Overvægt søger deltagere på steder i og omkring McKinney (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
RekruttererFase 2
- Revival Research Institute, LLC, McKinney
- Texas Institute of Cardiology, PA, McKinney
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
RekruttererFase 3
- North Dallas Research Associates, McKinney
- Texas Institute of Cardiology, McKinney
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
RekruttererFase 3
- Texas Institute of Cardiology, McKinney
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
RekruttererFase 3
- North Texas Research Associates, McKinney
Overvægt forsøg i andre byer
- Houston, TX43 studier
- Chicago, IL41 studier
- New York City, NY40 studier
- San Antonio, TX40 studier
- Washington, DC33 studier
- Orlando, FL31 studier
- Dallas, TX30 studier
- Boston, MA28 studier
- Las Vegas, NV27 studier
- Miami, FL27 studier
- Baltimore, MD25 studier
- Jacksonville, FL25 studier
Andre studier i McKinney
- Hjertesvigt7 studier
- Type 2-diabetes6 studier
- Astma5 studier
- KOL5 studier
- Kronisk nyresygdom4 studier
- Kardiovaskulær sygdom4 studier
- Aterosklerose3 studier
- Interstitielle lungesygdomme3 studier
- Graves sygdom3 studier
- Atrieflimmer3 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.